Mice deficient in CD80 and CD86 display reduced atherosclerosis and lower IFN-γ production by effector T cells, indicating that CD28-CD80/86 interactions prime T cells in atherosclerosis (137). This evidence concerns the gene CD28 and atherosclerosis.